Community pharmacy interventions for health promotion: Effects on professional practice and health outcomes

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 7, 2014, Pages

  Steed, Liz ^a   Kassavou, Aikaterini ^b   Madurasinghe, Vichithranie W ^a   Edwards, Elizabeth Ann ^a   Todd, Adam ^c   Summerbell, Carolyn D ^c   Nkansah, Nancy ^d   Bero, Lisa ^e   Durieux, Pierre ^f   Taylor, Stephanie J C ^a   Rivas, Carol ^a   Walton, R T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CLINICAL PRACTICE; CLINICAL PROTOCOL; COUNTRY ECONOMIC STATUS; ETHNICITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH PROMOTION; HUMAN; PHARMACIST; PHARMACY; PHARMACY TECHNICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SYSTEMATIC REVIEW;

EID: 85027403352     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011207     Document Type: Article

References (40)

1. Anderson CA, Blenkinsopp A, Armstrong M. Pharmacists' perceptions regarding their contribution to improving the publics health: A systematic review of the United Kindom and international literature. 1990-2001. International Journal of Pharmacy Practice 2003;11(2):111-20.
2. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al.Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007;62(6):496-502.
3. Bailey EJ, Cates CJ, Kruske SG, Morris PS, Brown N, Chang AB. Culture-specific programs for children and adults from minority groups who have asthma. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: ]
4. Benrimoj SI, Frommer MS. Community pharmacy in Australia. Australian Health Review 2004;28(2):238-46.
5. Cane J, O'Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation. Implementation Science 2012;7:37.
6. Chan XH, Wuliji T. Global Pharmacy Workforces and Migration Report: A call to action. www.fip.org/files/fip/publications/PharmacyWorkforceMigration.pdf (accessed 2nd March 2014) 2006.
7. Chandler J, Churchill R, Higgins J, Lasserson T, Tovey D. Methodological Standards for the conduct of new Cochrane Intervention Reviews. http://www.editorial-unit.cochrane.org/sites/editorial-unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.3%2002122013.pdf (accessed 5th March 2014) 02 December 2013; Vol. v 2.3.
8. Department of Health. Implementing the new Community Pharmacy Contractual Framework. webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/PublicationsandStatistics/Publications/PublicationsPolicyAndGuidance/DH_4109256 (accessed 2nd March 2014). London, 2005.
9. Department of Health. Pharmacy in England: Building on Strenghts - Delivering the Future. www.official-documents.gov.uk/document/cm73/7341/7341.pdf (accessed 2nd March 2014) 2008.
10. Eades CE, Ferguson JS, O'Carroll RE. Public health in community pharmacy: A systematic review of pharmacist and consumer views. BMC Public Health 2011;11:582-94.
11. Endnote. EndNote Collect, Collaborate, Create from Anywhere x6. Thomson Reuters, 2013.
12. Cochrane Effective Practice and Organisation of Care Review Group. Data collection checklist. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf (accessed 2nd March 2014) 2002.
13. EPOC. Suggested risk of bias criteria for EPOC reviews. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews.pdf (accessed 18th January 2014).
14. EPOC. What study designs should be included in an EPOC review and what should they be called?. epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/EPOC%20Study%20Designs%20About.pdf (accessed 18th January 2014).
15. Fidri-Benbrahim N, Faus M, Martinez-Martinez F, Gonzalez-Segura Alsina D, Sabater-Hernandez D. Effect of a pharmacist intervention in Spanish community pharmacies on blood presssure control in hypertensive patients. American Journal of Health-Systems Pharmacy 2012;69(15):1311-8.
16. Foster, G, Taylor SJ, Eldridge SE, Ramsay J, Griffiths CJ. Self-management education programmes by lay leaders for people with chronic conditions. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: ]
17. Gordon J, Watson M, Avenell A. Lightening the load? A systematic review of community based weight management interventions. Obesity Reviews 2011;12(11):897-911.
18. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
19. Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al.The Cochrane's tool for assessing risk of bias in randomised trials. BMJ 2011;343(9):d5928.
20. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from cochrane.handbook.org. The Cochrane Collaboration.
21. Michie, S. What works and how? Designing more effective interventions needs answers to both questions. Addiction 2008;103(6):886-7.
22. Michie S, Prestwich A. Are interventions theory-based? Development of a theory coding scheme. Health Psychology 2010;29(1):1-8.
23. Michie S, Johnston M, Abraham C, Francis J, Hardeman W, Eccles M. Developing a true (hierarchical) taxonomy of behaviour change techniques [abstract]. Psychology and Health 2012;27(S1):91.
24. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM, et al.Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: ]
25. Orwin RG. Evaluating coding decisions. In: Cooper H, Hedges LV editor(s). The Handbook of Research Synthesis. New York: Russel Sage Foundation, 1994.
26. Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: ]
27. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012; Vol. 5.2.
28. Royal Pharmaceutical Society of Great Britain. Pharmacy in a New Age, Summary of Responses. London: RPSGB, 1996.
29. Sarayani A, Rashidian A, Gohlami K, Torkamandi H, Javadi M. Efficacy of continuing education in improving pharmacists competencies for providing weight management service: Three arm randomized controlled trial. Journal of Continuing Education in the Health Professions 2012;32(3):163-73.
30. Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage of change model of smoking cessation: a randomised controlled trial in Scotland. Tobacco Control 1998;7(3):253-61.
31. Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database of Systematic Reviews 200, Issue 1. [DOI: ]
32. Smith F. The quality of private pharmacy services in low and middle-income countries: A systematic review. Pharmacy World & Science 2009;31(3):351-61.
33. Uebersax JS. Diversity of decision-making models and the measurement of interrater agreement. Psychological Bulletin 1987;101(1):140-6.
34. Watson MC, Blenkinsopp A. The feasibility of providing community pharmacy based services for alcohol misuse: A literature review. International Journal of Pharmacy Practice 2009;17(4):199-205.
35. World Health Organisation. The role of the pharmacist in self-care and self-medication. World Health Organisation 1998.
36. World Health Organization. New tool to enhance role of pharmacists in health care. www.who.int/mediacentre/news/new/2006/nw05/en/ (accessed 2nd March 2014) 2006.
37. World Health Organization. Milestones in Health Promotion: Statements from Global Conferences. www.who.int/healthpromotion/Milestones_Health_Promotion_05022010.pdf (accessed 2nd March 2014) 2009.
38. World Health Organization. Joint FIP/WHO guidelines on good pharmacy practice: Standards for quality of pharmacy services. www.who.int/medicines/areas/quality_safety/quality_assurance/FIPWHOGuidelinesGoodPharmacyPracticeTRS961Annex8.pdf (accessed 2nd March 2014) 2011; Vol. 961.
39. World Bank Group. Country and Lending Groups. data.worldbank.org/about/country-classifications/country-and-lending-groups (accessed 2nd March 2014) 2009.
40. Xu T, De Almedia Neto AC, Moles RJ. A systematic review of simulated-patient methods in community pharmacy to assess the provision of non-prescription medicines. International Journal of Pharmacy Practice 2012;20(5):307-19.